Use of proteomics for the identification of novel drug targets in brain diseases

Journal of Neurochemistry

Volumn 102, Issue 2, 2007, Pages 306-315

  Morón, Jose A ^a   Devi, Lakshmi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Brain; Brain disease; Protein profiling; Proteomics; Quantitative proteomics; Subcellular fractionation

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACONITATE HYDRATASE; DOPAMINE; GLUTATHIONE; MALONALDEHYDE; METHAMPHETAMINE; MORPHINE; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN DISEASE; BRAIN FUNCTION; BRAIN HOMOGENATE; BRAIN REGION; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG DEPENDENCE; ELECTROSPRAY MASS SPECTROMETRY; ENERGY METABOLISM; HIPPOCAMPUS; HUMAN; ISOTOPE LABELING; LEWY BODY; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE STRAIN; NONHUMAN; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT STRAIN; REVIEW; SUBSTANTIA NIGRA; TEMPORAL CORTEX;

ANIMALS; BRAIN; BRAIN CHEMISTRY; BRAIN DISEASES; DRUG DESIGN; HUMANS; NERVE TISSUE PROTEINS; NEUROCHEMISTRY; NEURODEGENERATIVE DISEASES; PROTEOMICS; SUBCELLULAR FRACTIONS;

EID: 34347205692     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04536.x     Document Type: Review

References (94)

1. Abul-Husn N. S. Devi L. A. (2006) Neuroproteomics of the synapse and drug addiction. J. Pharmacol. Exp. Ther. 318, 461 468.
2. Adamec E., Chang H. T., Stopa E. G., Hedreen J. C. Vonsattel J. P. (2001) Tau protein expression in frontotemporal dementias. Neurosci. Lett. 315, 21 24.
3. Aebersold R. Goodlett D. R. (2001) Mass spectrometry in proteomics. Chem. Rev. 101, 269 295.
4. Aebersold R. Mann M. (2003) Mass spectrometry-based proteomics. Nature 422, 198 207.
5. Alam Z. I., Daniel S. E., Lees A. J., Marsden D. C., Jenner P. Halliwell B. (1997a) A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69, 1326 1329.
6. Alam Z. I., Jenner A., Daniel S. E., Lees A. J., Cairns N., Marsden C. D., Jenner P. Halliwell B. (1997b) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69, 1196 1203.
7. Anderson L. Seilhamer J. (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18, 533 537.
8. Andreasen N., Vanmechelen E., Van de Voorde A., Davidsson P., Hesse C., Tarvonen S., Raiha I., Sourander L., Winblad B. Blennow K. (1998) Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. J. Neurol. Neurosurg. Psychiatry 64, 298 305.
9. Ashcroft A. E. (2003) Protein and peptide identification: the role of mass spectrometry in proteomics. Nat. Prod. Rep. 20, 202 215.
10. Barnidge D. R., Dratz E. A., Martin T., Bonilla L. E., Moran L. B. Lindall A. (2003) Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal. Chem. 75, 445 451.
11. Biser P. S., Thayne K. A., Fleming W. W. Taylor D. A. (2002) Na+, K+ ATPase alpha-subunit isoform distribution and abundance in guinea-pig longitudinal muscle/myenteric plexus after exposure to morphine. Brain Res. 931, 186 193.
12. Blume-Jensen P. Hunter T. (2001) Oncogenic kinase signalling. Nature 411, 355 365.
13. Bodzon-Kulakowska A., Bierczynska-Krzysik A., Drabik A., Noga M., Kraj A., Suder P. Silberring J. (2005) Morphinome-proteome of the nervous system after morphine treatment. Amino Acids 28, 13 19.
14. Buerger K., Zinkowski R., Teipel S. J. et al. (2002) Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch. Neurol. 59, 1267 1272.
15. Carlin R. K., Grab D. J., Cohen R. S. Siekevitz P. (1980) Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities. J. Cell Biol. 86, 831 845.
16. Castegna A., Aksenov M., Thongboonkerd V., Klein J. B., Pierce W. M., Booze R., Markesbery W. R. Butterfield D. A. (2002) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J. Neurochem. 82, 1524 1532.
17. Castegna A., Thongboonkerd V., Klein J. B., Lynn B., Markesbery W. R. Butterfield D. A. (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem. 85, 1394 1401.
18. Chen Y. A. Scheller R. H. (2001) SNARE-mediated membrane fusion. Nat. Rev. Mol. Cell Biol. 2, 98 106.
19. Cheng D., Hoogenraad C. C., Rush J. et al. (2006) Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol. Cell Proteomics 5, 1158 1170.
20. Collins M. O., Yu L., Coba M. P., Husi H., Campuzano I., Blackstock W. P., Choudhary J. S. Grant S. G. (2005) Proteomic analysis of in vivo phosphorylated synaptic proteins. J. Biol. Chem. 280, 5972 5982.
21. Cotman C. W., Banker G., Churchill L. Taylor D. (1974) Isolation of postsynaptic densities from rat brain. J. Cell Biol. 63, 441 455.
22. Dauer W. Przedborski S. (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889 909.
23. Dawson T. M. Dawson V. L. (2002) Neuroprotective and neurorestorative strategies for Parkinson's disease. Nat. Neurosci. 5 (Suppl. 1058 1061.
24. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P. Marsden C. D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381 389.
25. Dove A. (1999) Proteomics: translating genomics into products? Nat. Biotechnol. 17, 233 236.
26. Dunnett S. B. Bjorklund A. (1999) Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399, A32 A39.
27. Fenn J. B., Mann M., Meng C. K., Wong S. F. Whitehouse C. M. (1989) Electrospray ionization for mass spectrometry of large biomolecules. Science 246, 64 71.
28. Forno L. S. (1996) Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55, 259 272.
29. Gerber S. A., Rush J., Stemman O., Kirschner M. W. Gygi S. P. (2003) Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl Acad. Sci. USA 100, 6940 6945.
30. Gorg A., Postel W., Weser J., Patutschnick W. Cleve H. (1985) Improved resolution of PI (alpha 1-antitrypsin) phenotypes by a large-scale immobilized pH gradient. Am. J. Hum. Genet. 37, 922 930.
31. Graham D. G., Tiffany S. M., Bell W. R., Jr. Gutknecht W. F. (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14, 644 653.
32. Grant S. G. (2006) The synapse proteome and phosphoproteome: a new paradigm for synapse biology. Biochem. Soc. Trans. 34, 59 63.
33. Greenbaum D., Colangelo C., Williams K. Gerstein M. (2003) Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 4, 117.
34. Gygi S. P., Rochon Y., Franza B. R. Aebersold R. (1999a) Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 19, 1720 1730.
35. Gygi S. P., Rist B., Gerber S. A., Turecek F., Gelb M. H. Aebersold R. (1999b) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994 999.
36. Gygi S. P., Corthals G. L., Zhang Y., Rochon Y. Aebersold R. (2000) Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl Acad. Sci. USA 97, 9390 9395.
37. Haab B. B., Dunham M. J. Brown P. O. (2001) Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2, RESEARCH0004.
38. Halliwell B. (1999) Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic. Res. 31, 261 272.
39. Hu Y. Y., He S. S., Wang X., Duan Q. H., Grundke-Iqbal I., Iqbal K. Wang J. (2002) Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients: an ultrasensitive bienzyme-substrate- recycle enzyme-linked immunosorbent assay. Am. J. Pathol. 160, 1269 1278.
40. Huntley G. W., Benson D. L. Colman D. R. (2002) Structural remodeling of the synapse in response to physiological activity. Cell 108, 1 4.
41. Hutton M., Lewis J., Dickson D., Yen S. H. McGowan E. (2001) Analysis of tauopathies with transgenic mice. Trends Mol. Med. 7, 467 470.
42. Issaq H. J., Chan K. C., Janini G. M., Conrads T. P. Veenstra T. D. (2005) Multidimensional separation of peptides for effective proteomic analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 817, 35 47.
43. Iwazaki T., McGregor I. S. Matsumoto I. (2006) Protein expression profile in the striatum of acute methamphetamine-treated rats. Brain Res. 1097, 19 25.
44. Jin J., Meredith G. E., Chen L., Zhou Y., Xu J., Shie F. S., Lockhart P. Zhang J. (2005) Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res. Mol. Brain Res. 134, 119 138.
45. Jordan B. A., Fernholz B. D., Boussac M., Xu C., Grigorean G., Ziff E. B. Neubert T. A. (2004) Identification and verification of novel rodent postsynaptic density proteins. Mol. Cell Proteomics 3, 857 871.
46. Karas M., Gluckmann M. Schafer J. (2000) Ionization in matrix-assisted laser desorption/ionization: singly charged molecular ions are the lucky survivors. J. Mass Spectrom. 35, 1 12.
47. Kennedy M. B. (2000) Signal-processing machines at the postsynaptic density. Science 290, 750 754.
48. Kim S. I., Voshol H., van Oostrum J., Hastings T. G., Cascio M. Glucksman M. J. (2004) Neuroproteomics: expression profiling of the brain's proteomes in health and disease. Neurochem. Res. 29, 1317 1331.
49. Klose J. (1999) Large-gel 2-D electrophoresis. Methods Mol. Biol. 112, 147 172.
50. Koob G. F., Sanna P. P. Bloom F. E. (1998) Neuroscience of addiction. Neuron 21, 467 476.
51. Kudo T., Iqbal K., Ravid R., Swaab D. F. Grundke-Iqbal I. (1994) Alzheimer disease: correlation of cerebro-spinal fluid and brain ubiquitin levels. Brain Res. 639, 1 7.
52. Li K. W., Hornshaw M. P., Van Der Schors R. C. et al. (2004) Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology. J. Biol. Chem. 279, 987 1002.
53. Li K. W., Jimenez C. R., van der Schors R. C., Hornshaw M. P., Schoffelmeer A. N. Smit A. B. (2006) Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 6, 2003 2008.
54. Liao L., Cheng D., Wang J., Duong D. M., Losik T. G., Gearing M., Rees H. D., Lah J. J., Levey A. I. Peng J. (2004) Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J. Biol. Chem. 279, 37 061 37 068.
55. Lisman J., Schulman H. Cline H. (2002) The molecular basis of CaMKII function in synaptic and behavioural memory. Nat. Rev. Neurosci. 3, 175 190.
56. Madoz-Gurpide J., Wang H., Misek D. E., Brichory F. Hanash S. M. (2001) Protein based microarrays: a tool for probing the proteome of cancer cells and tissues. Proteomics 1, 1279 1287.
57. Malinow R. Malenka R. C. (2002) AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 25, 103 126.
58. Marcus K., Schmidt O., Schaefer H., Hamacher M., van Hall A. Meyer H. E. (2004) Proteomics-application to the brain. Int. Rev. Neurobiol. 61, 285 311.
59. Milner B., Squire L. R. Kandel E. R. (1998) Cognitive neuroscience and the study of memory. Neuron 20, 445 468.
60. Montine T. J., Farris D. B. Graham D. G. (1995) Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation. J. Neuropathol. Exp. Neurol. 54, 311 319.
61. Morón J. A., Abul-Husn N. S., Rozenfeld R., Dolios G., Wang R. Devi L. A. (2007) Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomic study focusing on endocytic proteins. Mol. Cell Proteomics 6, 29 42.
62. Mousavi S. A., Malerod L., Berg T. Kjeken R. (2004) Clathrin-dependent endocytosis. Biochem. J. 377, 1 16.
63. Norris E. H., Giasson B. I., Ischiropoulos H. Lee V. M. (2003) Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications. J. Biol. Chem. 278, 27 230 27 240.
64. Pearce R. K., Owen A., Daniel S., Jenner P. Marsden C. D. (1997) Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J. Neural Transm. 104, 661 677.
65. Peng J., Kim M. J., Cheng D., Duong D. M., Gygi S. P. Sheng M. (2004) Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J. Biol. Chem. 279, 21 003 21 011.
66. Perkins D. N., Pappin D. J., Creasy D. M. Cottrell J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551 3567.
67. Phillips G. R., Huang J. K., Wang Y. et al. (2001) The presynaptic particle web: ultrastructure, composition, dissolution, and reconstitution. Neuron 32, 63 77.
68. Phillips G. R., Florens L., Tanaka H., Khaing Z. Z., Fidler L., Yates J. R., III. Colman D. R. (2005) Proteomic comparison of two fractions derived from the transsynaptic scaffold. J. Neurosci. Res. 81, 762 775.
69. Prokai L., Zharikova A. D., Stevens S. M. Jr. (2005) Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry. J. Mass Spectrom. 40, 169 175.
70. Rabilloud T. (2002) Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2, 3 10.
71. Riederer B. M., Zagon I. S. Goodman S. R. (1986) Brain spectrin(240/235) and brain spectrin(240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells. J. Cell Biol. 102, 2088 2097.
72. Ross P. L., Huang Y. N., Marchese J. N. et al. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 3, 1154 1169.
73. Schmidt O., Schulenborg T., Meyer H. E., Marcus K. Hamacher M. (2005) How proteomics reveals potential biomarkers in brain diseases. Expert Rev. Proteomics 2, 901 913.
74. Schonberger S. J., Edgar P. F., Kydd R., Faull R. L. Cooper G. J. (2001) Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics 1, 1519 1528.
75. Shi Y., Xiang R., Horvath C. Wilkins J. A. (2004) The role of liquid chromatography in proteomics. J. Chromatogr. A 1053, 27 36.
76. Shoemaker D. D. Linsley P. S. (2002) Recent developments in DNA microarrays. Curr. Opin. Microbiol. 5, 334 337.
77. Slepnev V. I. De Camilli P. (2000) Accessory factors in clathrin-dependent synaptic vesicle endocytosis. Nat. Rev. Neurosci. 1, 161 172.
78. Soreghan B. A., Yang F., Thomas S. N., Hsu J. Yang A. J. (2003) High-throughput proteomic-based identification of oxidatively induced protein carbonylation in mouse brain. Pharm. Res. 20, 1713 1720.
79. Stears R. L., Martinsky T. Schena M. (2003) Trends in microarray analysis. Nat. Med. 9, 140 145.
80. Sultana R., Perluigi M. Butterfield D. A. (2006) Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox Signal. 8, 2021 2037.
81. Tilleman K., Stevens I., Spittaels K., Haute C. V., Clerens S., Van Den Bergh G., Geerts H., Van Leuven F., Vandesande F. Moens L. (2002) Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view. Proteomics 2, 94 104.
82. Tom Dieck S., Sanmarti-Vila L., Langnaese K. et al. (1998) Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals. J. Cell Biol. 142, 499 509.
83. Unlu M., Morgan M. E. Minden J. S. (1997) Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18, 2071 2077.
84. Voshol H., Glucksman M. J. van Oostrum J. (2003) Proteomics in the discovery of new therapeutic targets for psychiatric disease. Curr. Mol. Med. 3, 447 458.
85. Walikonis R. S., Jensen O. N., Mann M., Provance D. W. Jr., Mercer J. A. Kennedy M. B. (2000) Identification of proteins in the postsynaptic density fraction by mass spectrometry. J. Neurosci. 20, 4069 4080.
86. Wang G. P., Khatoon S., Iqbal K. Grundke-Iqbal I. (1991) Brain ubiquitin is markedly elevated in Alzheimer disease. Brain Res. 566, 146 151.
87. Wilkins M. R., Pasquali C., Appel R. D. et al. (1996) From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (NY) 14, 61 65.
88. Wilson K. E., Marouga R., Prime J. E. et al. (2005) Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling. Proteomics 5, 3851 3858.
89. Wolters D. A., Washburn M. P., Yates J. R. III. (2001) An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 73, 5683 5690.
90. Wu Q. Maniatis T. (1999) A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 97, 779 790.
91. Yates J. R. III., Eng J. K., McCormack A. L. Schieltz D. (1995) Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 67, 1426 1436.
92. Yoshimura Y., Yamauchi Y., Shinkawa T., Taoka M., Donai H., Takahashi N., Isobe T. Yamauchi T. (2004) Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-tandem mass spectrometry. J. Neurochem. 88, 759 768.
93. Zhang W. Chait B. T. (2000) ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal. Chem. 72, 2482 2489.
94. Ziff E. B. (1997) Enlightening the postsynaptic density. Neuron 19, 1163 1174.